Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Synovial × Dehydroepiandrosterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Polycystic Ovary Syndrome 2 Vaginal Atrophy 1 Triple Negative Breast Neoplasms 1 Sexual Dysfunction, Physiological 1 Sarcoma, Synovial 1 Rectal Neoplasms 1 Insulin Resistance 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Endocrine System Diseases 1 Depression 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Atrophic Vaginitis 1 Anxiety Disorders 1 Anus Neoplasms 1

Interventions

Doxorubicin 14 Cyclophosphamide 13 Ifosfamide 9 fludarabine 8 tazemetostat 5 Radiotherapy 5 pembrolizumab 4 Gemcitabine 4 pegfilgrastim 3 pazopanib 3 cixutumumab 3 Trabectedin 3 Filgrastim 3 Docetaxel 3 sargramostim 2 fludarabine phosphate 2 brostallicin 2 X-Rays 2 Sunitinib 2 Sorafenib 2 Radiation 2 Interferon-gamma 2 Immunotherapy, Adoptive 2 Imatinib Mesylate 2 Dacarbazine 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 trofosfamide 1 tremelimumab 1 temsirolimus 1 sotigalimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02683148 2019-09-09

DHEA in Synovial Sarcoma Patients

Washington University School of Medicine

Phase 1 Terminated

Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡